nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.36	1	CiPCiCtD
Fluticasone Propionate—CYP3A5—prostate cancer	0.0792	0.459	CbGaD
Fluticasone Propionate—NR3C1—prostate cancer	0.0592	0.343	CbGaD
Fluticasone Propionate—PLA2G4A—Epirubicin—prostate cancer	0.046	0.248	CbGbCtD
Fluticasone Propionate—CYP3A4—prostate cancer	0.0343	0.199	CbGaD
Fluticasone Propionate—CYP3A5—Flutamide—prostate cancer	0.0133	0.0716	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisone—prostate cancer	0.0133	0.0715	CbGbCtD
Fluticasone Propionate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0119	0.0642	CbGbCtD
Fluticasone Propionate—Prednicarbate—Prednisone—prostate cancer	0.0107	0.0676	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisone—prostate cancer	0.0104	0.0657	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisone—prostate cancer	0.0101	0.0639	CrCrCtD
Fluticasone Propionate—CYP3A5—Cabazitaxel—prostate cancer	0.00983	0.053	CbGbCtD
Fluticasone Propionate—Amcinonide—Prednisone—prostate cancer	0.00982	0.0622	CrCrCtD
Fluticasone Propionate—CYP3A5—Estrone—prostate cancer	0.00961	0.0518	CbGbCtD
Fluticasone Propionate—Clobetasol propionate—Prednisone—prostate cancer	0.00956	0.0605	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisone—prostate cancer	0.00956	0.0605	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisone—prostate cancer	0.00956	0.0605	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisone—prostate cancer	0.00932	0.059	CrCrCtD
Fluticasone Propionate—Desoximetasone—Prednisone—prostate cancer	0.0091	0.0576	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisone—prostate cancer	0.00888	0.0562	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisone—prostate cancer	0.00888	0.0562	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisone—prostate cancer	0.00888	0.0562	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisone—prostate cancer	0.00888	0.0562	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisone—prostate cancer	0.00868	0.0549	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisone—prostate cancer	0.00868	0.0549	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisone—prostate cancer	0.00868	0.0549	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisone—prostate cancer	0.0083	0.0526	CrCrCtD
Fluticasone Propionate—CYP3A7—Estradiol—prostate cancer	0.00736	0.0397	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00736	0.0397	CbGbCtD
Fluticasone Propionate—CYP3A4—Bicalutamide—prostate cancer	0.00625	0.0337	CbGbCtD
Fluticasone Propionate—CYP3A4—Estramustine—prostate cancer	0.00581	0.0313	CbGbCtD
Fluticasone Propionate—CYP3A5—Estradiol—prostate cancer	0.00552	0.0297	CbGbCtD
Fluticasone Propionate—CYP3A4—Flutamide—prostate cancer	0.00518	0.0279	CbGbCtD
Fluticasone Propionate—CYP3A4—Abiraterone—prostate cancer	0.00518	0.0279	CbGbCtD
Fluticasone Propionate—CYP3A7—Docetaxel—prostate cancer	0.0044	0.0237	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.0044	0.0237	CbGbCtD
Fluticasone Propionate—CYP3A4—Cabazitaxel—prostate cancer	0.00383	0.0207	CbGbCtD
Fluticasone Propionate—CYP3A4—Estrone—prostate cancer	0.00375	0.0202	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—prostate cancer	0.0036	0.0194	CbGbCtD
Fluticasone Propionate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00334	0.018	CbGbCtD
Fluticasone Propionate—CYP3A5—Docetaxel—prostate cancer	0.0033	0.0178	CbGbCtD
Fluticasone Propionate—CYP3A4—Conjugated Estrogens—prostate cancer	0.00245	0.0132	CbGbCtD
Fluticasone Propionate—CYP3A4—Mitoxantrone—prostate cancer	0.00223	0.012	CbGbCtD
Fluticasone Propionate—CYP3A4—Estradiol—prostate cancer	0.00215	0.0116	CbGbCtD
Fluticasone Propionate—CYP3A4—Prednisone—prostate cancer	0.00185	0.00997	CbGbCtD
Fluticasone Propionate—CYP3A4—Etoposide—prostate cancer	0.00141	0.00757	CbGbCtD
Fluticasone Propionate—CYP3A4—Docetaxel—prostate cancer	0.00129	0.00693	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—prostate cancer	0.000958	0.00517	CbGbCtD
Fluticasone Propionate—NR3C1—urine—prostate cancer	0.000919	0.0753	CbGeAlD
Fluticasone Propionate—PLA2G4A—prostate gland—prostate cancer	0.000757	0.062	CbGeAlD
Fluticasone Propionate—CYP3A4—urine—prostate cancer	0.000695	0.0569	CbGeAlD
Fluticasone Propionate—PLA2G4A—seminal vesicle—prostate cancer	0.00064	0.0524	CbGeAlD
Fluticasone Propionate—NR3C2—prostate gland—prostate cancer	0.000615	0.0504	CbGeAlD
Fluticasone Propionate—PGR—prostate gland—prostate cancer	0.000572	0.0468	CbGeAlD
Fluticasone Propionate—NR3C2—seminal vesicle—prostate cancer	0.00052	0.0426	CbGeAlD
Fluticasone Propionate—PLA2G4A—renal system—prostate cancer	0.000516	0.0422	CbGeAlD
Fluticasone Propionate—SERPINA6—renal system—prostate cancer	0.000514	0.0421	CbGeAlD
Fluticasone Propionate—PLA2G4A—urethra—prostate cancer	0.000507	0.0415	CbGeAlD
Fluticasone Propionate—PGR—epithelium—prostate cancer	0.00042	0.0344	CbGeAlD
Fluticasone Propionate—NR3C2—renal system—prostate cancer	0.000419	0.0343	CbGeAlD
Fluticasone Propionate—NR3C2—urethra—prostate cancer	0.000412	0.0337	CbGeAlD
Fluticasone Propionate—PLA2G4A—bone marrow—prostate cancer	0.00039	0.0319	CbGeAlD
Fluticasone Propionate—SERPINA6—bone marrow—prostate cancer	0.000388	0.0318	CbGeAlD
Fluticasone Propionate—PLA2G4A—testis—prostate cancer	0.000333	0.0273	CbGeAlD
Fluticasone Propionate—CYP3A5—prostate gland—prostate cancer	0.000333	0.0272	CbGeAlD
Fluticasone Propionate—NR3C1—prostate gland—prostate cancer	0.00033	0.027	CbGeAlD
Fluticasone Propionate—PLA2G4A—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.000313	0.262	CbGdCrCtD
Fluticasone Propionate—NR3C1—seminal vesicle—prostate cancer	0.000279	0.0229	CbGeAlD
Fluticasone Propionate—NR3C2—testis—prostate cancer	0.000271	0.0222	CbGeAlD
Fluticasone Propionate—PLA2G4A—Estradiol—Estramustine—prostate cancer	0.000266	0.223	CbGdCrCtD
Fluticasone Propionate—PGR—testis—prostate cancer	0.000252	0.0206	CbGeAlD
Fluticasone Propionate—NR3C1—epithelium—prostate cancer	0.000243	0.0199	CbGeAlD
Fluticasone Propionate—PLA2G4A—lymph node—prostate cancer	0.000242	0.0198	CbGeAlD
Fluticasone Propionate—CYP3A5—renal system—prostate cancer	0.000227	0.0186	CbGeAlD
Fluticasone Propionate—NR3C1—renal system—prostate cancer	0.000225	0.0184	CbGeAlD
Fluticasone Propionate—NR3C1—urethra—prostate cancer	0.000221	0.0181	CbGeAlD
Fluticasone Propionate—Amcinonide—ANXA1—prostate cancer	0.000213	0.106	CrCbGaD
Fluticasone Propionate—PLA2G4A—Estradiol—Estrone—prostate cancer	0.000212	0.177	CbGdCrCtD
Fluticasone Propionate—NR3C2—lymph node—prostate cancer	0.000196	0.0161	CbGeAlD
Fluticasone Propionate—PLA2G4A—Estradiol—Conjugated Estrogens—prostate cancer	0.000186	0.156	CbGdCrCtD
Fluticasone Propionate—PGR—lymph node—prostate cancer	0.000183	0.015	CbGeAlD
Fluticasone Propionate—CYP3A4—renal system—prostate cancer	0.00017	0.0139	CbGeAlD
Fluticasone Propionate—NR3C1—bone marrow—prostate cancer	0.00017	0.0139	CbGeAlD
Fluticasone Propionate—PLA2G4A—Estradiol—Ethinyl Estradiol—prostate cancer	0.000157	0.131	CbGdCrCtD
Fluticasone Propionate—NR3C1—testis—prostate cancer	0.000145	0.0119	CbGeAlD
Fluticasone Propionate—NR3C1—lymph node—prostate cancer	0.000105	0.00863	CbGeAlD
Fluticasone Propionate—Dexamethasone—CYP3A43—prostate cancer	8.45e-05	0.0422	CrCbGaD
Fluticasone Propionate—Difluprednate—NR3C1—prostate cancer	7.14e-05	0.0357	CrCbGaD
Fluticasone Propionate—Clocortolone—NR3C1—prostate cancer	6.93e-05	0.0346	CrCbGaD
Fluticasone Propionate—Prednicarbate—NR3C1—prostate cancer	6.93e-05	0.0346	CrCbGaD
Fluticasone Propionate—Dexamethasone—ANXA1—prostate cancer	6.68e-05	0.0333	CrCbGaD
Fluticasone Propionate—Diflorasone—NR3C1—prostate cancer	6.56e-05	0.0327	CrCbGaD
Fluticasone Propionate—Desoximetasone—NR3C1—prostate cancer	6.39e-05	0.0319	CrCbGaD
Fluticasone Propionate—Beclomethasone—CYP3A5—prostate cancer	5.98e-05	0.0298	CrCbGaD
Fluticasone Propionate—Flumethasone Pivalate—NR3C1—prostate cancer	5.5e-05	0.0275	CrCbGaD
Fluticasone Propionate—Halobetasol Propionate—NR3C1—prostate cancer	5.41e-05	0.027	CrCbGaD
Fluticasone Propionate—Amcinonide—NR3C1—prostate cancer	5.03e-05	0.0251	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—NR3C1—prostate cancer	4.94e-05	0.0246	CrCbGaD
Fluticasone Propionate—Mometasone—NR3C1—prostate cancer	4.79e-05	0.0239	CrCbGaD
Fluticasone Propionate—Rimexolone—NR3C1—prostate cancer	4.73e-05	0.0236	CrCbGaD
Fluticasone Propionate—Fluocinonide—NR3C1—prostate cancer	4.46e-05	0.0223	CrCbGaD
Fluticasone Propionate—Beclomethasone—NR3C1—prostate cancer	4.46e-05	0.0223	CrCbGaD
Fluticasone Propionate—Alclometasone—NR3C1—prostate cancer	4.34e-05	0.0217	CrCbGaD
Fluticasone Propionate—Fluocinolone Acetonide—NR3C1—prostate cancer	4.34e-05	0.0217	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—NR3C1—prostate cancer	4.22e-05	0.0211	CrCbGaD
Fluticasone Propionate—Flunisolide—NR3C1—prostate cancer	4.22e-05	0.0211	CrCbGaD
Fluticasone Propionate—Paramethasone—NR3C1—prostate cancer	4.17e-05	0.0208	CrCbGaD
Fluticasone Propionate—Fluorometholone—NR3C1—prostate cancer	4.07e-05	0.0203	CrCbGaD
Fluticasone Propionate—Methylprednisolone—NR3C1—prostate cancer	3.94e-05	0.0196	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—CYP1A1—prostate cancer	3.84e-05	0.0191	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP17A1—prostate cancer	3.84e-05	0.0191	CrCbGaD
Fluticasone Propionate—Betamethasone—CYP19A1—prostate cancer	3.35e-05	0.0167	CrCbGaD
Fluticasone Propionate—Triamcinolone—NR3C1—prostate cancer	3.32e-05	0.0166	CrCbGaD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisone—prostate cancer	3.06e-05	0.0256	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisone—prostate cancer	3.06e-05	0.0256	CbGdCrCtD
Fluticasone Propionate—Fluticasone furoate—CYP3A4—prostate cancer	2.86e-05	0.0143	CrCbGaD
Fluticasone Propionate—Betamethasone—NR3C1—prostate cancer	2.72e-05	0.0136	CrCbGaD
Fluticasone Propionate—Bronchitis—Epirubicin—prostate cancer	2.66e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Capecitabine—prostate cancer	2.66e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP1B1—prostate cancer	2.66e-05	0.0133	CrCbGaD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—prostate cancer	2.65e-05	0.000396	CcSEcCtD
Fluticasone Propionate—Eye disorder—Prednisone—prostate cancer	2.65e-05	0.000396	CcSEcCtD
Fluticasone Propionate—Vision blurred—Capecitabine—prostate cancer	2.61e-05	0.00039	CcSEcCtD
Fluticasone Propionate—Tremor—Capecitabine—prostate cancer	2.59e-05	0.000388	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—prostate cancer	2.58e-05	0.000386	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Epirubicin—prostate cancer	2.57e-05	0.000385	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Capecitabine—prostate cancer	2.57e-05	0.000384	CcSEcCtD
Fluticasone Propionate—Pruritus—Estradiol—prostate cancer	2.56e-05	0.000384	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—prostate cancer	2.56e-05	0.000383	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Prednisone—prostate cancer	2.56e-05	0.000383	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Prednisone—prostate cancer	2.53e-05	0.000379	CcSEcCtD
Fluticasone Propionate—Palpitations—Docetaxel—prostate cancer	2.53e-05	0.000378	CcSEcCtD
Fluticasone Propionate—Alclometasone—CYP3A4—prostate cancer	2.51e-05	0.0126	CrCbGaD
Fluticasone Propionate—Dyspnoea—Etoposide—prostate cancer	2.5e-05	0.000375	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Epirubicin—prostate cancer	2.5e-05	0.000374	CcSEcCtD
Fluticasone Propionate—Malaise—Capecitabine—prostate cancer	2.5e-05	0.000374	CcSEcCtD
Fluticasone Propionate—Cough—Docetaxel—prostate cancer	2.5e-05	0.000373	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Mitoxantrone—prostate cancer	2.49e-05	0.000372	CcSEcCtD
Fluticasone Propionate—Pneumonia—Epirubicin—prostate cancer	2.48e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Mental disorder—Prednisone—prostate cancer	2.48e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Estradiol—prostate cancer	2.48e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Hypertension—Docetaxel—prostate cancer	2.47e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Infestation—Epirubicin—prostate cancer	2.47e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Epirubicin—prostate cancer	2.47e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Malnutrition—Prednisone—prostate cancer	2.47e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Erythema—Prednisone—prostate cancer	2.47e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—prostate cancer	2.46e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Flunisolide—CYP3A4—prostate cancer	2.45e-05	0.0122	CrCbGaD
Fluticasone Propionate—Palpitations—Capecitabine—prostate cancer	2.45e-05	0.000366	CcSEcCtD
Fluticasone Propionate—Arthralgia—Docetaxel—prostate cancer	2.44e-05	0.000364	CcSEcCtD
Fluticasone Propionate—Chest pain—Docetaxel—prostate cancer	2.44e-05	0.000364	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	2.42e-05	0.000362	CcSEcCtD
Fluticasone Propionate—Paramethasone—CYP3A4—prostate cancer	2.42e-05	0.0121	CrCbGaD
Fluticasone Propionate—Cough—Capecitabine—prostate cancer	2.42e-05	0.000361	CcSEcCtD
Fluticasone Propionate—Pain—Etoposide—prostate cancer	2.4e-05	0.000359	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Epirubicin—prostate cancer	2.4e-05	0.000359	CcSEcCtD
Fluticasone Propionate—Dizziness—Estradiol—prostate cancer	2.4e-05	0.000358	CcSEcCtD
Fluticasone Propionate—Hypertension—Capecitabine—prostate cancer	2.39e-05	0.000358	CcSEcCtD
Fluticasone Propionate—Dry mouth—Docetaxel—prostate cancer	2.38e-05	0.000356	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—prostate cancer	2.38e-05	0.000356	CcSEcCtD
Fluticasone Propionate—Fluorometholone—CYP3A4—prostate cancer	2.36e-05	0.0118	CrCbGaD
Fluticasone Propionate—Arthralgia—Capecitabine—prostate cancer	2.36e-05	0.000353	CcSEcCtD
Fluticasone Propionate—Chest pain—Capecitabine—prostate cancer	2.36e-05	0.000353	CcSEcCtD
Fluticasone Propionate—Anxiety—Capecitabine—prostate cancer	2.35e-05	0.000351	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	2.34e-05	0.00035	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Docetaxel—prostate cancer	2.33e-05	0.000349	CcSEcCtD
Fluticasone Propionate—Oedema—Docetaxel—prostate cancer	2.33e-05	0.000349	CcSEcCtD
Fluticasone Propionate—Discomfort—Capecitabine—prostate cancer	2.33e-05	0.000348	CcSEcCtD
Fluticasone Propionate—Epistaxis—Epirubicin—prostate cancer	2.33e-05	0.000348	CcSEcCtD
Fluticasone Propionate—Vision blurred—Prednisone—prostate cancer	2.32e-05	0.000348	CcSEcCtD
Fluticasone Propionate—Infection—Docetaxel—prostate cancer	2.32e-05	0.000347	CcSEcCtD
Fluticasone Propionate—Sinusitis—Epirubicin—prostate cancer	2.32e-05	0.000346	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Etoposide—prostate cancer	2.31e-05	0.000346	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—prostate cancer	2.31e-05	0.000346	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mitoxantrone—prostate cancer	2.31e-05	0.000346	CcSEcCtD
Fluticasone Propionate—Dry mouth—Capecitabine—prostate cancer	2.31e-05	0.000345	CcSEcCtD
Fluticasone Propionate—Vomiting—Estradiol—prostate cancer	2.3e-05	0.000345	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—prostate cancer	2.3e-05	0.000344	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Etoposide—prostate cancer	2.3e-05	0.000344	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Docetaxel—prostate cancer	2.29e-05	0.000342	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Prednisone—prostate cancer	2.29e-05	0.000342	CcSEcCtD
Fluticasone Propionate—Rash—Estradiol—prostate cancer	2.29e-05	0.000342	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—prostate cancer	2.28e-05	0.000342	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—prostate cancer	2.28e-05	0.000342	CcSEcCtD
Fluticasone Propionate—Dermatitis—Estradiol—prostate cancer	2.28e-05	0.000341	CcSEcCtD
Fluticasone Propionate—Methylprednisolone—CYP3A4—prostate cancer	2.28e-05	0.0114	CrCbGaD
Fluticasone Propionate—Tachycardia—Docetaxel—prostate cancer	2.28e-05	0.000341	CcSEcCtD
Fluticasone Propionate—Headache—Estradiol—prostate cancer	2.27e-05	0.00034	CcSEcCtD
Fluticasone Propionate—Skin disorder—Docetaxel—prostate cancer	2.27e-05	0.000339	CcSEcCtD
Fluticasone Propionate—Agitation—Prednisone—prostate cancer	2.27e-05	0.000339	CcSEcCtD
Fluticasone Propionate—Oedema—Capecitabine—prostate cancer	2.26e-05	0.000338	CcSEcCtD
Fluticasone Propionate—Angioedema—Prednisone—prostate cancer	2.25e-05	0.000337	CcSEcCtD
Fluticasone Propionate—Infection—Capecitabine—prostate cancer	2.25e-05	0.000336	CcSEcCtD
Fluticasone Propionate—Urticaria—Etoposide—prostate cancer	2.23e-05	0.000334	CcSEcCtD
Fluticasone Propionate—Malaise—Prednisone—prostate cancer	2.22e-05	0.000333	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—prostate cancer	2.22e-05	0.000332	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—prostate cancer	2.22e-05	0.000332	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—prostate cancer	2.22e-05	0.000332	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Capecitabine—prostate cancer	2.22e-05	0.000332	CcSEcCtD
Fluticasone Propionate—Tachycardia—Capecitabine—prostate cancer	2.21e-05	0.00033	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—prostate cancer	2.21e-05	0.00033	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—prostate cancer	2.2e-05	0.000329	CcSEcCtD
Fluticasone Propionate—Skin disorder—Capecitabine—prostate cancer	2.2e-05	0.000328	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—prostate cancer	2.18e-05	0.000326	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—prostate cancer	2.15e-05	0.000322	CcSEcCtD
Fluticasone Propionate—Nausea—Estradiol—prostate cancer	2.15e-05	0.000322	CcSEcCtD
Fluticasone Propionate—Vomiting—Mitoxantrone—prostate cancer	2.15e-05	0.000321	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—prostate cancer	2.14e-05	0.000321	CcSEcCtD
Fluticasone Propionate—Hypertension—Prednisone—prostate cancer	2.13e-05	0.000319	CcSEcCtD
Fluticasone Propionate—Rash—Mitoxantrone—prostate cancer	2.13e-05	0.000318	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mitoxantrone—prostate cancer	2.13e-05	0.000318	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.13e-05	0.000318	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP3A5—prostate cancer	2.12e-05	0.0106	CrCbGaD
Fluticasone Propionate—Headache—Mitoxantrone—prostate cancer	2.12e-05	0.000316	CcSEcCtD
Fluticasone Propionate—Arthralgia—Prednisone—prostate cancer	2.1e-05	0.000314	CcSEcCtD
Fluticasone Propionate—Anxiety—Prednisone—prostate cancer	2.09e-05	0.000313	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.09e-05	0.000312	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Docetaxel—prostate cancer	2.08e-05	0.000311	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisone—prostate cancer	2.07e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—prostate cancer	2.07e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—prostate cancer	2.07e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.06e-05	0.000308	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—prostate cancer	2.06e-05	0.000308	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP2A6—prostate cancer	2.05e-05	0.0102	CrCbGaD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—prostate cancer	2.04e-05	0.000305	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—prostate cancer	2.04e-05	0.000304	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—prostate cancer	2.02e-05	0.000301	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Capecitabine—prostate cancer	2.01e-05	0.000301	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisone—prostate cancer	2.01e-05	0.000301	CcSEcCtD
Fluticasone Propionate—Oedema—Prednisone—prostate cancer	2.01e-05	0.000301	CcSEcCtD
Fluticasone Propionate—Nausea—Mitoxantrone—prostate cancer	2.01e-05	0.0003	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—prostate cancer	2e-05	0.000299	CcSEcCtD
Fluticasone Propionate—Infection—Prednisone—prostate cancer	2e-05	0.000299	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—prostate cancer	2e-05	0.000299	CcSEcCtD
Fluticasone Propionate—Pain—Docetaxel—prostate cancer	2e-05	0.000299	CcSEcCtD
Fluticasone Propionate—Pruritus—Etoposide—prostate cancer	1.99e-05	0.000297	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Epirubicin—prostate cancer	1.98e-05	0.000296	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Prednisone—prostate cancer	1.97e-05	0.000295	CcSEcCtD
Fluticasone Propionate—Tachycardia—Prednisone—prostate cancer	1.96e-05	0.000294	CcSEcCtD
Fluticasone Propionate—Skin disorder—Prednisone—prostate cancer	1.96e-05	0.000292	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP19A1—prostate cancer	1.95e-05	0.00974	CrCbGaD
Fluticasone Propionate—Mental disorder—Epirubicin—prostate cancer	1.94e-05	0.00029	CcSEcCtD
Fluticasone Propionate—Pain—Capecitabine—prostate cancer	1.93e-05	0.000289	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—prostate cancer	1.93e-05	0.000289	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—prostate cancer	1.93e-05	0.000289	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Docetaxel—prostate cancer	1.92e-05	0.000288	CcSEcCtD
Fluticasone Propionate—Triamcinolone—CYP3A4—prostate cancer	1.92e-05	0.0096	CrCbGaD
Fluticasone Propionate—Diarrhoea—Etoposide—prostate cancer	1.92e-05	0.000287	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—prostate cancer	1.92e-05	0.000287	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Docetaxel—prostate cancer	1.91e-05	0.000286	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—prostate cancer	1.9e-05	0.000285	CcSEcCtD
Fluticasone Propionate—Triamcinolone—PTGS2—prostate cancer	1.88e-05	0.0094	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Capecitabine—prostate cancer	1.86e-05	0.000279	CcSEcCtD
Fluticasone Propionate—Dizziness—Etoposide—prostate cancer	1.86e-05	0.000278	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Epirubicin—prostate cancer	1.85e-05	0.000277	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—prostate cancer	1.85e-05	0.000277	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Capecitabine—prostate cancer	1.85e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—prostate cancer	1.85e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Docetaxel—prostate cancer	1.85e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Docetaxel—prostate cancer	1.85e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Prednisone—prostate cancer	1.83e-05	0.000274	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—prostate cancer	1.83e-05	0.000274	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—prostate cancer	1.82e-05	0.000272	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—prostate cancer	1.8e-05	0.000269	CcSEcCtD
Fluticasone Propionate—Urticaria—Capecitabine—prostate cancer	1.8e-05	0.000269	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—prostate cancer	1.79e-05	0.000268	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Capecitabine—prostate cancer	1.79e-05	0.000267	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Capecitabine—prostate cancer	1.79e-05	0.000267	CcSEcCtD
Fluticasone Propionate—Vomiting—Etoposide—prostate cancer	1.79e-05	0.000267	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—prostate cancer	1.79e-05	0.000267	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—prostate cancer	1.79e-05	0.000267	CcSEcCtD
Fluticasone Propionate—Agitation—Epirubicin—prostate cancer	1.77e-05	0.000265	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—prostate cancer	1.77e-05	0.000265	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—prostate cancer	1.77e-05	0.000265	CcSEcCtD
Fluticasone Propionate—Headache—Etoposide—prostate cancer	1.76e-05	0.000263	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—prostate cancer	1.74e-05	0.00026	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Docetaxel—prostate cancer	1.72e-05	0.000257	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—prostate cancer	1.72e-05	0.000257	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—prostate cancer	1.7e-05	0.000255	CcSEcCtD
Fluticasone Propionate—Cough—Epirubicin—prostate cancer	1.68e-05	0.000252	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—prostate cancer	1.68e-05	0.000252	CcSEcCtD
Fluticasone Propionate—Nausea—Etoposide—prostate cancer	1.67e-05	0.00025	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—prostate cancer	1.67e-05	0.000249	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Capecitabine—prostate cancer	1.67e-05	0.000249	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Prednisone—prostate cancer	1.66e-05	0.000248	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—prostate cancer	1.66e-05	0.000248	CcSEcCtD
Fluticasone Propionate—Pruritus—Docetaxel—prostate cancer	1.65e-05	0.000247	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Prednisone—prostate cancer	1.65e-05	0.000246	CcSEcCtD
Fluticasone Propionate—Arthralgia—Epirubicin—prostate cancer	1.64e-05	0.000246	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—prostate cancer	1.64e-05	0.000246	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—prostate cancer	1.64e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—prostate cancer	1.64e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.63e-05	0.000244	CcSEcCtD
Fluticasone Propionate—Discomfort—Epirubicin—prostate cancer	1.62e-05	0.000243	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—prostate cancer	1.61e-05	0.000241	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—prostate cancer	1.61e-05	0.00024	CcSEcCtD
Fluticasone Propionate—Urticaria—Prednisone—prostate cancer	1.6e-05	0.000239	CcSEcCtD
Fluticasone Propionate—Pruritus—Capecitabine—prostate cancer	1.6e-05	0.000239	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Docetaxel—prostate cancer	1.6e-05	0.000239	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Prednisone—prostate cancer	1.59e-05	0.000238	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Prednisone—prostate cancer	1.59e-05	0.000238	CcSEcCtD
Fluticasone Propionate—Dexamethasone—NR3C1—prostate cancer	1.58e-05	0.00789	CrCbGaD
Fluticasone Propionate—Palpitations—Doxorubicin—prostate cancer	1.58e-05	0.000236	CcSEcCtD
Fluticasone Propionate—Betamethasone—CYP3A4—prostate cancer	1.58e-05	0.00787	CrCbGaD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—prostate cancer	1.57e-05	0.000235	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—prostate cancer	1.57e-05	0.000235	CcSEcCtD
Fluticasone Propionate—Infection—Epirubicin—prostate cancer	1.56e-05	0.000234	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—prostate cancer	1.56e-05	0.000233	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Capecitabine—prostate cancer	1.55e-05	0.000231	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—prostate cancer	1.54e-05	0.000231	CcSEcCtD
Fluticasone Propionate—Dizziness—Docetaxel—prostate cancer	1.54e-05	0.000231	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—prostate cancer	1.54e-05	0.0077	CrCbGaD
Fluticasone Propionate—Hypertension—Doxorubicin—prostate cancer	1.54e-05	0.000231	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—prostate cancer	1.54e-05	0.00023	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—prostate cancer	1.53e-05	0.000229	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—prostate cancer	1.52e-05	0.000227	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—prostate cancer	1.52e-05	0.000227	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—prostate cancer	1.51e-05	0.000227	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.51e-05	0.000226	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—prostate cancer	1.5e-05	0.000225	CcSEcCtD
Fluticasone Propionate—Dizziness—Capecitabine—prostate cancer	1.49e-05	0.000224	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—prostate cancer	1.49e-05	0.000222	CcSEcCtD
Fluticasone Propionate—Vomiting—Docetaxel—prostate cancer	1.48e-05	0.000222	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Prednisone—prostate cancer	1.48e-05	0.000222	CcSEcCtD
Fluticasone Propionate—Rash—Docetaxel—prostate cancer	1.47e-05	0.00022	CcSEcCtD
Fluticasone Propionate—Dermatitis—Docetaxel—prostate cancer	1.47e-05	0.00022	CcSEcCtD
Fluticasone Propionate—Headache—Docetaxel—prostate cancer	1.46e-05	0.000219	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—prostate cancer	1.46e-05	0.000218	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—prostate cancer	1.46e-05	0.000218	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP2E1—prostate cancer	1.46e-05	0.00726	CrCbGaD
Fluticasone Propionate—Infection—Doxorubicin—prostate cancer	1.45e-05	0.000216	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP2C19—prostate cancer	1.44e-05	0.00719	CrCbGaD
Fluticasone Propionate—Vomiting—Capecitabine—prostate cancer	1.44e-05	0.000215	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP1A1—prostate cancer	1.44e-05	0.00717	CrCbGaD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.43e-05	0.000215	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—prostate cancer	1.43e-05	0.000214	CcSEcCtD
Fluticasone Propionate—Rash—Capecitabine—prostate cancer	1.43e-05	0.000213	CcSEcCtD
Fluticasone Propionate—Pruritus—Prednisone—prostate cancer	1.42e-05	0.000213	CcSEcCtD
Fluticasone Propionate—Dermatitis—Capecitabine—prostate cancer	1.42e-05	0.000213	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—prostate cancer	1.42e-05	0.000213	CcSEcCtD
Fluticasone Propionate—Headache—Capecitabine—prostate cancer	1.42e-05	0.000212	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—prostate cancer	1.42e-05	0.000212	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Epirubicin—prostate cancer	1.4e-05	0.00021	CcSEcCtD
Fluticasone Propionate—Nausea—Docetaxel—prostate cancer	1.39e-05	0.000207	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Prednisone—prostate cancer	1.38e-05	0.000206	CcSEcCtD
Fluticasone Propionate—Pain—Epirubicin—prostate cancer	1.35e-05	0.000201	CcSEcCtD
Fluticasone Propionate—Nausea—Capecitabine—prostate cancer	1.34e-05	0.000201	CcSEcCtD
Fluticasone Propionate—Dizziness—Prednisone—prostate cancer	1.33e-05	0.000199	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.33e-05	0.000199	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—prostate cancer	1.3e-05	0.000194	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—prostate cancer	1.3e-05	0.000194	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—prostate cancer	1.29e-05	0.000193	CcSEcCtD
Fluticasone Propionate—Vomiting—Prednisone—prostate cancer	1.28e-05	0.000191	CcSEcCtD
Fluticasone Propionate—Rash—Prednisone—prostate cancer	1.27e-05	0.00019	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisone—prostate cancer	1.27e-05	0.00019	CcSEcCtD
Fluticasone Propionate—Headache—Prednisone—prostate cancer	1.26e-05	0.000189	CcSEcCtD
Fluticasone Propionate—Urticaria—Epirubicin—prostate cancer	1.25e-05	0.000187	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—prostate cancer	1.25e-05	0.000186	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—prostate cancer	1.24e-05	0.000186	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Epirubicin—prostate cancer	1.24e-05	0.000186	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—prostate cancer	1.2e-05	0.00018	CcSEcCtD
Fluticasone Propionate—Nausea—Prednisone—prostate cancer	1.2e-05	0.000179	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—prostate cancer	1.19e-05	0.000178	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Epirubicin—prostate cancer	1.16e-05	0.000174	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—prostate cancer	1.16e-05	0.000173	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—prostate cancer	1.15e-05	0.000172	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—prostate cancer	1.15e-05	0.000172	CcSEcCtD
Fluticasone Propionate—Pruritus—Epirubicin—prostate cancer	1.11e-05	0.000167	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Epirubicin—prostate cancer	1.08e-05	0.000161	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Fluticasone Propionate—Dizziness—Epirubicin—prostate cancer	1.04e-05	0.000156	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—prostate cancer	1.03e-05	0.000154	CcSEcCtD
Fluticasone Propionate—Vomiting—Epirubicin—prostate cancer	1e-05	0.00015	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—prostate cancer	9.97e-06	0.000149	CcSEcCtD
Fluticasone Propionate—Rash—Epirubicin—prostate cancer	9.93e-06	0.000148	CcSEcCtD
Fluticasone Propionate—Dermatitis—Epirubicin—prostate cancer	9.92e-06	0.000148	CcSEcCtD
Fluticasone Propionate—Headache—Epirubicin—prostate cancer	9.86e-06	0.000148	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—prostate cancer	9.63e-06	0.000144	CcSEcCtD
Fluticasone Propionate—Nausea—Epirubicin—prostate cancer	9.35e-06	0.00014	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—prostate cancer	9.26e-06	0.000139	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—prostate cancer	9.19e-06	0.000137	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—prostate cancer	9.18e-06	0.000137	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP3A4—prostate cancer	9.16e-06	0.00458	CrCbGaD
Fluticasone Propionate—Headache—Doxorubicin—prostate cancer	9.13e-06	0.000137	CcSEcCtD
Fluticasone Propionate—Dexamethasone—PTGS2—prostate cancer	8.97e-06	0.00448	CrCbGaD
Fluticasone Propionate—Nausea—Doxorubicin—prostate cancer	8.65e-06	0.000129	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.54e-06	6.18e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—prostate cancer	2.52e-06	6.14e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	2.52e-06	6.13e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB3—prostate cancer	2.51e-06	6.1e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGFR2—prostate cancer	2.5e-06	6.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—COMT—prostate cancer	2.49e-06	6.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1C3—prostate cancer	2.48e-06	6.04e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—prostate cancer	2.48e-06	6.03e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—prostate cancer	2.48e-06	6.03e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTP1—prostate cancer	2.47e-06	6.02e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PRKACB—prostate cancer	2.47e-06	6e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGF—prostate cancer	2.45e-06	5.96e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS1—prostate cancer	2.45e-06	5.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP17A1—prostate cancer	2.44e-06	5.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ITPR1—prostate cancer	2.43e-06	5.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—prostate cancer	2.42e-06	5.89e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—prostate cancer	2.41e-06	5.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—prostate cancer	2.4e-06	5.85e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—B4GALT4—prostate cancer	2.4e-06	5.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HPGD—prostate cancer	2.4e-06	5.84e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—prostate cancer	2.39e-06	5.81e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GSK3B—prostate cancer	2.38e-06	5.79e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—INS—prostate cancer	2.35e-06	5.71e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR1—prostate cancer	2.33e-06	5.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOA2—prostate cancer	2.33e-06	5.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMS—prostate cancer	2.3e-06	5.6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—prostate cancer	2.3e-06	5.59e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CREBBP—prostate cancer	2.3e-06	5.59e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—INS—prostate cancer	2.29e-06	5.58e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—prostate cancer	2.28e-06	5.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—prostate cancer	2.27e-06	5.53e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—prostate cancer	2.27e-06	5.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TNFRSF21—prostate cancer	2.26e-06	5.49e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CREBBP—prostate cancer	2.25e-06	5.47e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—prostate cancer	2.24e-06	5.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LPL—prostate cancer	2.23e-06	5.43e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CAV1—prostate cancer	2.22e-06	5.41e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC5A5—prostate cancer	2.22e-06	5.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—prostate cancer	2.2e-06	5.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.2e-06	5.34e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTAP—prostate cancer	2.2e-06	5.34e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAP2K1—prostate cancer	2.19e-06	5.34e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CD—prostate cancer	2.18e-06	5.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2E1—prostate cancer	2.17e-06	5.28e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SERPINE1—prostate cancer	2.16e-06	5.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A1—prostate cancer	2.16e-06	5.24e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NQO1—prostate cancer	2.14e-06	5.22e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ESR1—prostate cancer	2.14e-06	5.21e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.14e-06	5.21e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.14e-06	5.21e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ERCC2—prostate cancer	2.14e-06	5.2e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CD—prostate cancer	2.13e-06	5.18e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TH—prostate cancer	2.11e-06	5.14e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—prostate cancer	2.1e-06	5.11e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BAD—prostate cancer	2.09e-06	5.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP3A4—prostate cancer	2.09e-06	5.09e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGF2—prostate cancer	2.09e-06	5.08e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—prostate cancer	2.06e-06	5.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1B1—prostate cancer	2.06e-06	5e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CREBBP—prostate cancer	2.04e-06	4.97e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACSL4—prostate cancer	2.04e-06	4.97e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.04e-06	4.97e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—prostate cancer	2.03e-06	4.93e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—prostate cancer	2.03e-06	4.93e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—prostate cancer	2.01e-06	4.89e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—prostate cancer	2.01e-06	4.89e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGF—prostate cancer	2e-06	4.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS1—prostate cancer	2e-06	4.87e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JAK2—prostate cancer	2e-06	4.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GGT1—prostate cancer	1.99e-06	4.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARA—prostate cancer	1.97e-06	4.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOA1—prostate cancer	1.96e-06	4.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ARG2—prostate cancer	1.96e-06	4.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PHGDH—prostate cancer	1.96e-06	4.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UMPS—prostate cancer	1.96e-06	4.76e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MDM2—prostate cancer	1.95e-06	4.75e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GSK3B—prostate cancer	1.94e-06	4.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP19A1—prostate cancer	1.93e-06	4.7e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—prostate cancer	1.93e-06	4.68e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LDHB—prostate cancer	1.92e-06	4.67e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INS—prostate cancer	1.92e-06	4.67e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SERPINE1—prostate cancer	1.92e-06	4.66e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CB—prostate cancer	1.9e-06	4.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.88e-06	4.58e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CREBBP—prostate cancer	1.88e-06	4.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—RXRA—prostate cancer	1.87e-06	4.54e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CB—prostate cancer	1.86e-06	4.52e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—prostate cancer	1.85e-06	4.51e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAV1—prostate cancer	1.85e-06	4.51e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—prostate cancer	1.85e-06	4.49e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—prostate cancer	1.84e-06	4.48e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—prostate cancer	1.83e-06	4.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PDHA1—prostate cancer	1.82e-06	4.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TCN2—prostate cancer	1.82e-06	4.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UCP3—prostate cancer	1.82e-06	4.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA3—prostate cancer	1.82e-06	4.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—COMT—prostate cancer	1.8e-06	4.37e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAP2K1—prostate cancer	1.79e-06	4.36e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTP1—prostate cancer	1.79e-06	4.35e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—prostate cancer	1.78e-06	4.34e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CD—prostate cancer	1.78e-06	4.33e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SERPINE1—prostate cancer	1.76e-06	4.29e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ITPR1—prostate cancer	1.76e-06	4.28e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—prostate cancer	1.75e-06	4.25e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—prostate cancer	1.74e-06	4.25e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—prostate cancer	1.74e-06	4.24e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.74e-06	4.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.74e-06	4.22e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGF2—prostate cancer	1.7e-06	4.15e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—prostate cancer	1.7e-06	4.14e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—prostate cancer	1.69e-06	4.11e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—prostate cancer	1.68e-06	4.1e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—prostate cancer	1.68e-06	4.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.66e-06	4.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA4—prostate cancer	1.66e-06	4.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMS—prostate cancer	1.66e-06	4.05e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—prostate cancer	1.65e-06	4.02e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—prostate cancer	1.65e-06	4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—prostate cancer	1.64e-06	4e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—prostate cancer	1.64e-06	3.99e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAK2—prostate cancer	1.63e-06	3.98e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA2—prostate cancer	1.62e-06	3.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LPL—prostate cancer	1.61e-06	3.93e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—prostate cancer	1.6e-06	3.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCG5—prostate cancer	1.6e-06	3.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.6e-06	3.9e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—prostate cancer	1.6e-06	3.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—INS—prostate cancer	1.6e-06	3.89e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MDM2—prostate cancer	1.6e-06	3.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—prostate cancer	1.57e-06	3.83e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EP300—prostate cancer	1.57e-06	3.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CREBBP—prostate cancer	1.57e-06	3.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA1—prostate cancer	1.56e-06	3.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A1—prostate cancer	1.56e-06	3.79e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CB—prostate cancer	1.55e-06	3.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.55e-06	3.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTO1—prostate cancer	1.55e-06	3.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NAT2—prostate cancer	1.55e-06	3.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ERCC2—prostate cancer	1.55e-06	3.76e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—EP300—prostate cancer	1.53e-06	3.72e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SRC—prostate cancer	1.52e-06	3.7e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—prostate cancer	1.49e-06	3.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CD—prostate cancer	1.48e-06	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LRP2—prostate cancer	1.48e-06	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.48e-06	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLCB2—prostate cancer	1.48e-06	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—prostate cancer	1.48e-06	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—prostate cancer	1.47e-06	3.57e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—prostate cancer	1.46e-06	3.54e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—prostate cancer	1.46e-06	3.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—P4HB—prostate cancer	1.45e-06	3.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—prostate cancer	1.45e-06	3.53e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—prostate cancer	1.43e-06	3.47e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—prostate cancer	1.43e-06	3.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARA—prostate cancer	1.42e-06	3.47e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—prostate cancer	1.42e-06	3.45e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.41e-06	3.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—prostate cancer	1.4e-06	3.41e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—prostate cancer	1.39e-06	3.38e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.38e-06	3.35e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—prostate cancer	1.38e-06	3.35e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—prostate cancer	1.36e-06	3.32e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—prostate cancer	1.36e-06	3.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MED12—prostate cancer	1.36e-06	3.3e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—prostate cancer	1.35e-06	3.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNG5—prostate cancer	1.35e-06	3.27e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—prostate cancer	1.34e-06	3.27e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—prostate cancer	1.34e-06	3.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAV1—prostate cancer	1.34e-06	3.26e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—prostate cancer	1.33e-06	3.25e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—prostate cancer	1.31e-06	3.18e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA3—prostate cancer	1.3e-06	3.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.29e-06	3.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—prostate cancer	1.28e-06	3.12e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EP300—prostate cancer	1.28e-06	3.11e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—prostate cancer	1.26e-06	3.07e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SRC—prostate cancer	1.24e-06	3.03e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HPGDS—prostate cancer	1.24e-06	3.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.23e-06	2.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.22e-06	2.97e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—prostate cancer	1.21e-06	2.95e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—prostate cancer	1.21e-06	2.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—prostate cancer	1.2e-06	2.92e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACHE—prostate cancer	1.2e-06	2.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—prostate cancer	1.2e-06	2.92e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.19e-06	2.88e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—prostate cancer	1.16e-06	2.82e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—INS—prostate cancer	1.16e-06	2.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.15e-06	2.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PRKACB—prostate cancer	1.15e-06	2.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.14e-06	2.76e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—prostate cancer	1.13e-06	2.75e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CREBBP—prostate cancer	1.13e-06	2.75e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—prostate cancer	1.12e-06	2.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—prostate cancer	1.12e-06	2.72e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—prostate cancer	1.11e-06	2.71e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—prostate cancer	1.11e-06	2.71e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—prostate cancer	1.09e-06	2.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA2—prostate cancer	1.08e-06	2.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.07e-06	2.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—EP300—prostate cancer	1.07e-06	2.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.03e-06	2.51e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—prostate cancer	1.03e-06	2.51e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—prostate cancer	1.03e-06	2.5e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—prostate cancer	1.01e-06	2.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.01e-06	2.45e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NQO1—prostate cancer	9.97e-07	2.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TH—prostate cancer	9.82e-07	2.39e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1B1—prostate cancer	9.56e-07	2.33e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—prostate cancer	9.46e-07	2.3e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—prostate cancer	9.46e-07	2.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CB—prostate cancer	9.35e-07	2.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—prostate cancer	9.26e-07	2.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GGT1—prostate cancer	9.26e-07	2.25e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—prostate cancer	9.24e-07	2.25e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—prostate cancer	9.15e-07	2.23e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA1—prostate cancer	9.12e-07	2.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP19A1—prostate cancer	8.98e-07	2.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RXRA—prostate cancer	8.67e-07	2.11e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—prostate cancer	8.41e-07	2.05e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—prostate cancer	8.38e-07	2.04e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—COMT—prostate cancer	8.35e-07	2.03e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTP1—prostate cancer	8.31e-07	2.02e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ITPR1—prostate cancer	8.18e-07	1.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—prostate cancer	8.08e-07	1.97e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—prostate cancer	7.88e-07	1.92e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMS—prostate cancer	7.73e-07	1.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—prostate cancer	7.73e-07	1.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—EP300—prostate cancer	7.71e-07	1.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—prostate cancer	7.64e-07	1.86e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPL—prostate cancer	7.5e-07	1.82e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A1—prostate cancer	7.24e-07	1.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ERCC2—prostate cancer	7.18e-07	1.75e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—prostate cancer	6.75e-07	1.64e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARA—prostate cancer	6.62e-07	1.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—prostate cancer	6.44e-07	1.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAV1—prostate cancer	6.23e-07	1.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—prostate cancer	5.7e-07	1.39e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.67e-07	1.38e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—INS—prostate cancer	5.37e-07	1.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CREBBP—prostate cancer	5.26e-07	1.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.99e-07	1.21e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—prostate cancer	4.71e-07	1.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—prostate cancer	4.66e-07	1.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.35e-07	1.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—prostate cancer	4.31e-07	1.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—prostate cancer	3.76e-07	9.14e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—EP300—prostate cancer	3.58e-07	8.72e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.65e-07	6.45e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—prostate cancer	2.16e-07	5.27e-06	CbGpPWpGaD
